Clinical trial

CPAP for the Treatment of Supine Hypertension

NCT05489575

Study summary

ClinicalTrials.gov

CPAP for the Treatment of Supine Hypertension

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention Active CPAP Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Sham CPAP Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Sleeping in a head-up tilt (HUT) position Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2022-06-23

PhaseNA

Conditions

Autonomic Failureunresolved

Pure Autonomic Failureverified · MONDO: pure autonomic failure

Multiple System Atrophyverified · MONDO: multiple system atrophy

Parkinson Diseaseverified · MONDO: Parkinson disease

Supine Hypertensionunresolved

Neurogenic Orthostatic Hypotensionunresolved

Interventions

Active CPAPDEVICE

Sham CPAPDEVICE

Sleeping in a head-up tilt (HUT) positionOTHER

Sponsors & collaborators

Vanderbilt University Medical Centerlead sponsor

National Heart, Lung, and Blood Institute (NHLBI)collaborator

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05489575 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.